🦴 CPT 60500 — Parathyroidectomy or Exploration of Parathyroid(s)
Quick Reference
wRVU: 15.21 | Global Period: 090 | Assistant Payable: Yes | Bilateral Indicator: 0 Rule: CPT 60500 carries a bilateral indicator of “0,” meaning the bilateral payment concept doesn’t apply — the code descriptor already contemplates exploration of any/all parathyroid glands in a single session, so modifier -50 and laterality modifiers -RT/-LT are not used. It has a 90-day global surgical package, is assistant-surgeon payable, and is frequently reported with an add-on code when autotransplantation is performed in the same operative session.
📋 Clinical Description
CPT 60500 describes a cervical exploration of the parathyroid glands, with removal of one or more glands as clinically indicated, most commonly performed for primary hyperparathyroidism caused by a solitary adenoma, multigland hyperplasia, or (rarely) parathyroid carcinoma. The surgeon accesses the neck through a low collar incision, identifies the four parathyroid glands (or as many as can be located), and resects abnormal tissue while preserving normal glands and the recurrent laryngeal nerves. Unlike 60502, which is reserved for reoperative cases, 60500 is reported only for the patient’s initial parathyroid exploration regardless of whether one, two, three, or all four glands are ultimately removed.
Documentation must clearly support that this was a dedicated parathyroid procedure and not an incidental finding during thyroid surgery, since NCCI edits bundle 60500 into 60240 when both are performed together for the same encounter. Intraoperative PTH monitoring is frequently used to confirm biochemical cure but is not separately billable when performed by the operating surgeon as part of the global package. Compared to 60505, which adds mediastinal exploration via sternal split or thoracic approach for ectopic or mediastinal parathyroid tissue, 60500 is limited to standard cervical anatomy and does not support the additional RVU value assigned to the more invasive approach.
This procedure may be performed in the following clinical contexts:
- Primary hyperparathyroidism — bilateral neck exploration or focused/minimally invasive exploration to remove a solitary adenoma identified on preoperative sestamibi scan or ultrasound.
- Multigland hyperplasia — subtotal (3.5-gland) or total parathyroidectomy with autotransplantation, often in the setting of MEN1 or MEN2A syndromes.
- Secondary or tertiary hyperparathyroidism of renal origin — performed in dialysis-dependent or post-transplant patients with refractory hypercalcemia despite medical management.
- Suspected parathyroid carcinoma — en bloc exploration with careful attention to capsule integrity to avoid tumor seeding.
- Inpatient encounter following failed outpatient localization — patient admitted for four-gland exploration when imaging fails to localize a single adenoma.
🔬 Anatomical & Procedural Considerations
| Variant | Mechanism | Key Notes |
|---|---|---|
| Focused/Minimally Invasive Exploration | A targeted approach guided by preoperative imaging (sestamibi, 4D-CT, or ultrasound) that limits dissection to the localized gland, often paired with intraoperative PTH monitoring to confirm biochemical cure before closing. This approach reduces operative time and postoperative hypocalcemia risk compared to full four-gland exploration. It is still reported with 60500 since CPT does not differentiate by incision size or extent of dissection. | |
| Bilateral Four-Gland Exploration | Traditional approach in which all four parathyroid glands are visually identified and assessed for size and appearance before deciding which to remove. This remains the standard for multigland hyperplasia, familial hyperparathyroidism syndromes, or when preoperative imaging fails to localize a single adenoma. Higher risk of transient hypocalcemia and recurrent laryngeal nerve injury due to more extensive dissection. | |
| Subtotal/Total Parathyroidectomy with Autotransplantation | Removal of 3.5 or all 4 glands with reimplantation of a portion of the most normal-appearing gland into the forearm or sternocleidomastoid muscle, typically for renal hyperparathyroidism or hereditary hyperplasia. The autotransplantation is reported separately with add-on code 60512. Requires close postoperative calcium monitoring given the high likelihood of transient or permanent hypoparathyroidism. |
Clinical Pearl
The single biggest audit risk with 60500 is reporting it alongside a thyroidectomy code without documentation clearly establishing medical necessity for a distinct parathyroid exploration, since NCCI treats parathyroid exploration as inherently included in thyroidectomy unless the operative note demonstrates a separately identifiable indication and modifier -59 (or an appropriate X{EPSU} modifier) is supported.
✅ Procedure Includes
- Cervical incision, subplatysmal flap elevation, and strap muscle retraction to expose the thyroid bed and parathyroid glands.
- Visual identification of all accessible parathyroid glands with assessment of size, color, and vascularity.
- Excision or resection of one or more abnormal glands, with hemostasis and specimen handling for frozen section pathology.
- Identification and preservation of the recurrent laryngeal nerve(s) during dissection.
- Intraoperative decision-making regarding extent of resection based on gross appearance and (when used) rapid PTH assay trends.
- Routine wound closure and standard postoperative care included in the 90-day global period.
❌ Excludes / Do Not Report Together
| Code | Description | Relationship |
|---|---|---|
| 60502 | Parathyroidectomy or exploration of parathyroid(s); re-exploration | Reserved exclusively for a subsequent parathyroid exploration after a prior parathyroid surgery; reporting 60500 for a documented reoperative case is a specificity error that understates the additional RVU value tied to scar tissue and altered anatomy. |
| 60505 | Parathyroidectomy or exploration of parathyroid(s); with mediastinal exploration, sternal split, or transthoracic approach | Used only when the operative approach extends beyond the standard cervical field into the mediastinum; 60500 should never be reported in addition to 60505 for the same gland exploration. |
| 60512 | Parathyroid autotransplantation (List separately in addition to code for primary procedure) | An add-on code, never billed alone; append only when documentation confirms glandular tissue was reimplanted into a separate site (forearm or muscle) during the same session as 60500. |
| 60240 | Thyroidectomy, total or complete | NCCI bundles 60500 into 60240 as a column 2 edit because incidental parathyroid identification is considered part of standard thyroidectomy technique; separate reporting requires clear documentation of a distinct, medically necessary parathyroid indication. |
Bundling Alert
Because 60500 carries a 90-day global period, any related E/M visits, wound checks, or minor postoperative procedures within that window are bundled into the global fee and cannot be billed separately without an appropriate modifier (-24, -78, or -79 as clinically supported). Auditors frequently flag claims pairing 60500 with 60240 on the same date without modifier -59/-XS support, and payers may deny the parathyroid code outright if the operative note does not independently justify the exploration. Reoperative cases inappropriately reported as 60500 instead of 60502 are another common audit trigger, since the RVU differential between the two codes is substantial.
🌳 Code Tree — Surgery: Endocrine System
CPT 60000-60699 Surgery: Endocrine System
│
├── 60200-60281 Excision (Thyroid Gland)
│ ├── 60220 Total thyroid lobectomy, unilateral; with or without isthmusectomy
│ └── 60225 Total thyroid lobectomy, unilateral; with contralateral subtotal lobectomy, including isthmusectomy
│
├── 60500-60605 Excision (Parathyroid, Thymus, Adrenal, Pancreas, Carotid Body)
│ ├── 60212 Partial thyroid lobectomy, unilateral; with contralateral subtotal lobectomy, including isthmusectomy (Global: 090)
│ ├── 60240 Thyroidectomy, total or complete (Global: 090)
│ ├── ▶▶ 60500 ◀◀ Parathyroidectomy or exploration of parathyroid(s) ← YOU ARE HERE (Global: 090)
│ ├── 60502 Parathyroidectomy or exploration of parathyroid(s); re-exploration (Global: 090)
│ ├── 60505 Parathyroidectomy or exploration of parathyroid(s); with mediastinal exploration, sternal split, or transthoracic approach (Global: 090)
│ └── 60512 Parathyroid autotransplantation (List separately in addition to code for primary procedure) (Global: ZZZ)
│
├── 60540-60545 Excision (Adrenal Gland)
│
└── 60600-60699 Excision (Carotid Body)
├── 60600 Excision of carotid body tumor; without excision of carotid artery
└── 60605 Excision of carotid body tumor; with excision of carotid artery💰 RVU & Reimbursement Profile
| Component | Value |
|---|---|
| Work RVU | 15.21 |
| Global Period | 090 |
| Bilateral Indicator | 0 — bilateral payment adjustment concept does not apply |
| Assistant Surgeon | Yes, payable with modifier -80/-82 when documentation supports medical necessity |
| Co‑Surgeon | Yes, payable with modifier -62 when two surgeons of different specialties (e.g., ENT and general/endocrine surgery) each perform a distinct part of the procedure |
| Team Surgery | Not typically applicable |
| PC/TC Split | 0 — global surgical service, professional/technical split does not apply |
| Modifier -51 Exempt | No |
| Anesthesia | General anesthesia; typically reported under anesthesia CPT 00320 (neck procedures) by the anesthesia provider |
Bilateral Billing Rules
🏷️ Modifier Reference
| Modifier | Name | When to Apply |
|---|---|---|
| -22 | Increased Procedural Services | Apply when documentation shows substantially greater work than typical — extensive scarring from prior neck surgery unrelated to the parathyroid, ectopic gland requiring prolonged dissection, or unusual anatomic distortion — supported by a comparison statement in the operative note. |
| -25 | Significant, Separately Identifiable E/M | Applies to a same-day E/M service (e.g., inpatient admission workup) that is significant and separately identifiable from the decision for surgery; not used on the procedure code itself. |
| -51 | Multiple Procedures | Append when 60500 is billed with other significant procedures during the same operative session that are not add-on codes, to reflect standard multiple-procedure payment reduction. |
| -59 | Distinct Procedural Service | Used to override the NCCI edit bundling 60500 into 60240 when documentation clearly supports that the parathyroid exploration was a separate, medically necessary service distinct from the thyroidectomy. |
| -62 | Two Surgeons | Applies when two surgeons of different specialties each perform a distinct portion of the parathyroidectomy, each reporting 60500 with modifier -62 and separate operative documentation. |
| -78 | Unplanned Return to OR | Append when the patient returns to the OR during the 90-day global period for a complication of the original parathyroidectomy, such as a hematoma requiring evacuation. |
| -79 | Unrelated Procedure by Same Physician During Postoperative Period | Applies when the same surgeon performs an unrelated procedure during the global period, such as a subsequent thyroid nodule biopsy unrelated to the parathyroid surgery. |
| -80 | Assistant Surgeon | Applies when a second physician actively assists throughout the procedure rather than performing a distinct portion, common for complex or reoperative cases. |
| -82 | Assistant Surgeon (when qualified resident not available) | Used in teaching hospital settings when a qualified resident surgeon is not available to assist. |
🩺 Common ICD‑10‑CM Pairings
Primary Diagnosis Group
| ICD‑10 | Description | HCC? | Notes |
|---|---|---|---|
| E21.0 | Primary hyperparathyroidism | Yes | The most common driving diagnosis for 60500; supports medical necessity when paired with elevated PTH and calcium lab values in the documentation. |
| E21.1 | Secondary hyperparathyroidism, not elsewhere classified | Yes | Used for non-renal secondary causes (e.g., vitamin D deficiency, malabsorption); renal-origin cases should instead use N25.81. |
| E21.3 | Hyperparathyroidism, unspecified | No | A nonspecific fallback code; auditors flag its use when the operative and pathology reports support a more specific etiology such as E21.0. |
| D35.1 | Benign neoplasm of parathyroid gland | No | Applies when pathology confirms a benign adenoma without functional hyperparathyroidism documentation, distinct from E21.0 which implies a hormonally active lesion. |
| C75.0 | Malignant neoplasm of parathyroid gland | Yes | Rare; requires confirmed pathology and should be sequenced carefully against any hypercalcemia of malignancy codes. |
Secondary Group
| ICD‑10 | Description | HCC? | Notes |
|---|---|---|---|
| E83.52 | Hypercalcemia | No | Commonly reported as a secondary diagnosis reflecting the biochemical abnormality driving surgical intervention. |
| N25.81 | Secondary hyperparathyroidism of renal origin | Yes | Use for dialysis-dependent or chronic kidney disease patients undergoing subtotal/total parathyroidectomy; pair with the applicable CKD stage code. |
Etiology / Complication
| ICD‑10 | Description | HCC? | Notes |
|---|---|---|---|
| E89.2 | Postprocedural hypoparathyroidism | Yes | Reported for iatrogenic hypoparathyroidism identified after the parathyroidectomy, common with total or subtotal gland removal. |
| E83.51 | Hypocalcemia | No | Frequently reported postoperatively to support continued calcium monitoring and supplementation orders during the admission. |
Coding Specificity Reminder
Always confirm the pathology report before finalizing the primary diagnosis — a documented adenoma with confirmed hyperfunction supports E21.0, while an incidentally excised gland without functional hyperparathyroidism documentation should default to D35.1. Renal-origin secondary hyperparathyroidism must be captured with N25.81 rather than E21.1 to reflect the correct clinical etiology and support accurate risk adjustment.
🏥 MS‑DRG Considerations
Inpatient encounters reporting the PCS equivalents of CPT 60500 group to the Thyroid, Parathyroid, and Thyroglossal Procedures DRG triad (625/626/627), with the presence of a documented MCC (such as postoperative hypocalcemic tetany or acute kidney injury) or CC (such as postoperative hypoparathyroidism) determining whether the encounter groups to the higher-weighted DRG 625 or 626 versus the baseline DRG 627. Coders should ensure that any complication meeting CC/MCC criteria is clearly documented as related to the surgical encounter and coded to the highest specificity, since these secondary diagnoses materially affect the payment weight. Sequencing the correct principal diagnosis (typically the specific hyperparathyroidism etiology code) ahead of secondary complication codes is essential for accurate DRG assignment.
🔧 ICD‑10‑PCS Equivalents
| PCS Code | Full Description | Modality |
|---|---|---|
| 0GTR0ZZ | Resection of Parathyroid Gland, Open Approach | Open |
| 0GTR4ZZ | Resection of Parathyroid Gland, Percutaneous Endoscopic Approach | Endoscopic |
| 0GBR0ZZ | Excision of Parathyroid Gland, Open Approach | Open |
| 0GBR4ZZ | Excision of Parathyroid Gland, Percutaneous Endoscopic Approach | Endoscopic |
PCS Character Analysis
| Position | Character | Value | Definition |
|---|---|---|---|
| 1 | Section | 0 | Medical and Surgical section, covering the vast majority of inpatient operative procedures. |
| 2 | Body System | G | Endocrine System, the body system grouping that includes the parathyroid, thyroid, pituitary, pineal, and adrenal glands. |
| 3 | Root Operation | T or B | T (Resection) is used when all parathyroid tissue is removed, such as a total or subtotal parathyroidectomy; B (Excision) applies when only a portion of the glandular tissue is removed, such as excision of a single adenoma with other glands left intact. |
| 4 | Body Part | R | Parathyroid Gland, the single body part value used regardless of how many of the four individual glands are addressed during the encounter. |
| 5 | Approach | 0 or 4 | 0 (Open) reflects the standard cervical incision approach; 4 (Percutaneous Endoscopic) applies to minimally invasive video-assisted parathyroidectomy technique. |
| 6 | Device | Z | No Device, since no implant, graft, or other device is left in place during a standard parathyroid excision or resection. |
| 7 | Qualifier | Z | No Qualifier, as no additional qualifying detail applies to this body part and root operation combination. |
Root Operation Comparison
- Resection (T) is the correct root operation whenever documentation confirms all parathyroid tissue was removed, such as a total or complete four-gland parathyroidectomy performed for multigland hyperplasia.
- Excision (B) applies when a single adenoma or a subset of glands is removed while other parathyroid tissue is deliberately left in place, which is the more common scenario for focused single-adenoma surgery.
- Coders should cross-reference the operative note’s stated extent of resection against the pathology specimen count to select the correct root operation rather than defaulting to one value for every case.
📝 Coding Examples
Example 1
Clinical Scenario: A 58-year-old female is admitted with symptomatic primary hyperparathyroidism, elevated serum calcium of 11.8 mg/dL, and PTH of 145 pg/mL. Preoperative sestamibi scan localizes a single right inferior parathyroid adenoma. The surgeon performs a focused right neck exploration, identifies and excises the enlarged gland, and confirms an appropriate intraoperative PTH drop of greater than 50%. No other glands are explored. Frozen section confirms parathyroid adenoma tissue.
| Field | Code | Rationale |
|---|---|---|
| CPT | 60500 | Reported once regardless of focused versus four-gland approach, since the code descriptor does not differentiate by extent of exploration. |
| PDx | E21.0 | Primary hyperparathyroidism is confirmed by both biochemical findings and pathology-confirmed adenoma with hormonal hyperfunction. |
Note
Documentation of the intraoperative PTH decline supports medical necessity and biochemical cure but is not separately billable; it is included in the global surgical package for 60500.
Example 2
Clinical Scenario: A 64-year-old male with end-stage renal disease on hemodialysis is admitted for refractory secondary hyperparathyroidism unresponsive to cinacalcet therapy. The surgeon performs a subtotal (3.5-gland) parathyroidectomy with cryopreservation of remaining tissue, then autotransplants a portion of the most normal-appearing gland into the left forearm brachioradialis muscle during the same operative session.
| Field | Code | Rationale |
|---|---|---|
| CPT 1 | 60500 | Reports the primary parathyroid exploration and subtotal resection performed in the initial surgical session. |
| CPT 2 | 60512 | Add-on code correctly appended for the autotransplantation performed during the same session as the primary procedure. |
| PDx | N25.81 | Correctly identifies renal-origin secondary hyperparathyroidism rather than the non-renal E21.1 code, reflecting the patient’s ESRD etiology. |
Warning
Example 3
Clinical Scenario: A 47-year-old female undergoes an inpatient total thyroidectomy for a multinodular goiter. During the procedure, the surgeon incidentally identifies and preserves all four parathyroid glands without removing any tissue, documenting only routine visual identification as part of standard thyroidectomy technique. No separate parathyroid pathology, elevated calcium, or elevated PTH is documented anywhere in the chart.
| Field | Code | Rationale |
|---|---|---|
| CPT | 60240 | The thyroidectomy is the only billable procedure since the parathyroid glands were merely identified and preserved, not separately explored or excised. |
| PDx | E04.2 | Nontoxic multinodular goiter is the correct principal diagnosis driving the thyroidectomy; no parathyroid diagnosis is supported since no separate pathology exists. |
Global period reminder
This scenario is a classic overcoding trap: routine intraoperative visualization of parathyroid glands during thyroidectomy does not meet the threshold to separately report 60500. Reporting it here without a distinct indication would trigger an NCCI bundling denial or, worse, an unbundling audit flag if paid in error.
⚠️ Common Coding Pitfalls
- Pitfall 1: Reporting 60500 alongside 60240 without documentation establishing a distinct, medically necessary parathyroid indication. NCCI bundles these codes by default, and payers will deny 60500 unless modifier -59/-XS is supported by clear operative documentation of separate pathology.
- Pitfall 2: Using 60500 for a documented reoperative case instead of 60502. Prior operative history in the chart should always be reviewed before code selection, since the RVU differential between the two codes is significant and audit-sensitive.
- Pitfall 3: Appending modifier -50 or laterality modifiers -RT/-LT to 60500. The code’s bilateral indicator of 0 means these modifiers are not applicable and will typically trigger a claim edit or denial.
- Pitfall 4: Failing to append 60512 when autotransplantation is performed, or conversely billing 60512 without a corresponding primary parathyroidectomy code on the same claim.
- Pitfall 5: Defaulting to the unspecified E21.3 diagnosis code when the pathology report and clinical documentation actually support a more specific etiology such as E21.0 or N25.81, weakening both medical necessity support and risk adjustment accuracy.
- Pitfall 6: Selecting ICD-10-PCS root operation Excision (B) when the operative note documents complete removal of all parathyroid tissue, which should instead be coded as Resection (T); this affects DRG assignment accuracy on the facility side.
📎 Sources
> No NCD specifically governs CPT 60500 itself; coverage is determined under general Medicare medical necessity criteria for surgical treatment of hyperparathyroidism.1 A related LCD (L34018, Parathormone/Parathyroid Hormone) governs coverage of the PTH lab test frequently ordered pre- and intraoperatively but does not itself restrict coverage of the surgical procedure.2 1. Medtronic ENT Thyroid and Parathyroid Procedures Coding and Payment Guide, effective January 1, 2026 - December 31, 2026. 2. CMS Medicare Coverage Database, LCD L34018 — Parathormone (Parathyroid Hormone), accessed July 2026. 3. CMS National Correct Coding Initiative (NCCI) Policy Manual, effective February 28, 2026. 4. AAPC Codify, CPT Code 60500 reference and coding discussion, accessed July 2026. 5. CMS ICD-10-CM/PCS MS-DRG Definitions Manual, DRGs 625-627.Sources listed above correspond to superscript citations throughout this note. Verify all Medicare payment figures against your current CMS PFS Lookup tool and applicable MAC LCD prior to claim submission. Please use the latest AAPC/AHIMA Coding Books to verify each code within this note.